Citation

Alkhayyat M, Abou Saleh M, Coronado W, Abureesh M, Al-Otoom O, Qapaja T, Mansoor E, Simons-Linares CR, Stevens T, Chahal P. Pancreas 2021; 50(2): 153-159.

Copyright

(Copyright © 2021, Lippincott Williams and Wilkins)

DOI

10.1097/MPA.0000000000001746

PMID

33565791

Abstract

OBJECTIVES: Chronic pancreatitis (CP) is often associated with poor quality of life. Only a few small associative studies have reported the prevalence of mood disorders in CP. Using a large database, we sought to describe the epidemiology and risk association of anxiety and depression in CP and evaluate their outcomes.
METHODS: A multicenter database (Explorys), an aggregate of electronic health record data from 26 US healthcare systems, was surveyed. A cohort of patients with a diagnosis of CP between 2014 and 2019 was identified. Within this cohort, rates of anxiety and depression were calculated. Demographics, comorbidities, and outcomes were described.
RESULTS: Of the 30,276,810 individuals in the database (2014-2019), 67,260 patients had a CP diagnosis (0.22%). When compared with patients with no history of CP, patients with CP were more likely to develop anxiety (odds ratio, 6.94; 95% confidence interval, 6.85-7.04) and depression (odds ratio, 5.09; 95% confidence interval, 5.01-5.17). Chronic pancreatitis patients with depression had an increased risk of suicidal ideation compared with controls.
CONCLUSIONS: Patients with CP are at a higher risk of developing anxiety and depression compared with those without CP, with overall worse outcomes. Clinicians should screen CP patients and make appropriate referral to psychiatry when indicated.

Language: en

Keywords

Humans; Risk Factors; United States; Adult; Aged; Female; Male; Middle Aged; Anxiety; Depression; Retrospective Studies; Risk Assessment; Young Adult; Aged, 80 and over; Substance-Related Disorders; Comorbidity; Time Factors; Prevalence; Suicidal Ideation; Databases, Factual; Psychotropic Drugs; Pancreatitis, Chronic